ZBH · 8-K · 20260805PR335108
Guidance / Outlook
ZIMMER BIOMET HOLDINGS, INC. · 2026-08-05 · Importance 68 · Surprise 68 · No source text
Management expects 2026 net sales growth of 2.5 percent to 4.5 percent. The outlook includes a 1.0 percent contribution from the Paragon 28 acquisition until the deal’s one-year anniversary in April 2026 and a 0.5 percent positive foreign-currency contribution. Operating profit is expected to increase in 2026, although inflation, U.S. commercial-channel investments, higher net interest expense and a higher estimated effective tax rate may offset part of the improvement.
Key facts
- 2026 outlook expects year-over-year net sales growth of 2.5 percent to 4.5 percent. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | +3.0% | 2026 outlook expects year-over-year net sales growth of 2.5 percent to 4.5 percent. |